Dhara Rail Projects IPO is a book build issue of ₹50.20 crore. The issue is a completely fresh issue of 0.40 crore shares, worth ₹50.20 crore.

Dhara Rail Projects IPO will open for subscription on December 23, 2025 and close on December 26, 2025.

The allotment of Dhara Rail Projects IPO is expected to be final on December 29, 2025. Dhara Rail Projects IPO will be listed on NSE SME, the probable listing date of which has been fixed as December 31, 2025.

Apollo Techno Industries IPO is a book-building issue of ₹47.96 crore, in which a total of 0.37 crore new shares will be issued. This IPO will open for subscription on December 23, 2025 and will close on December 26, 2025.

The allotment of shares is likely to be finalized on December 29, 2025. The company’s shares will be listed on the BSE SME platform, the probable listing date of which has been fixed as December 31, 2025.

The price band of this IPO has been kept at ₹123 to ₹130 per share. This issue is being brought to support the company’s expansion and future growth plans.

Nephrocare Health IPO is much discussed among investors. This is a Book Build Issue of ₹871.05 crore which includes Fresh Issue of ₹353.40 crore and Offer For Sale (OFS) of ₹517.64 crore. Bidding for IPO started on 10 December 2025 and will close on 12 December 2025. Allotment is expected on 15 December 2025 and this share will be listed on BSE and NSE on 17 December 2025. The price band of this IPO has been fixed at ₹438 to ₹460 per share. For Retail Investors, one lot will contain 32 shares, for which the minimum investment amount will be ₹ 14,720 (at the upper price brand). Whereas for SMNI, a bid of 14 Lot (₹ 2,06,080) will have to be made and for bNII, 68 Lot (₹ 10,00,960) will have to be bid. There is also a special reservation for employees in this issue—83,532 shares, which will be given at a discount of ₹41. The Book Running Lead Manager of this IPO is ICICI Securities and Kfin Technologies is playing the role of Registrar. Nephrocare Health is a leading company providing Kidney Care and Diagnostic Services in India. Be sure to consult your financial advisor before investing in IPO. For more information see Nephrocare Health IPO RHP.

Corona Remedies IPO is a book build issue of ₹655.37 crore. The issue is an offer for sale of 0.62 crore shares worth ₹655.37 crore. Bidding for Corona Remedies IPO will open for subscription on December 8, 2025 and will close on December 10, 2025. The allotment of Corona Remedies IPO is expected to be finalized on December 11, 2025. Corona Remedies IPO will be listed on BSE, NSE, with the probable listing date fixed at December 15, 2025. The price band of Corona Remedies IPO has been fixed at ₹1008.00 to ₹1062.00 per share. The lot size for one application is 14. The minimum investment amount required for a retail investor is ₹14,868 (14 shares) (based on cap price). The lot size investment for sNII is 14 lots (196 shares), amounting to ₹2,08,152, and for bNII it is 68 lots (952 shares), amounting to ₹10,11,024. The issue includes reservation of 58,036 shares for employees, which are being offered at a discount of ₹54.00 to the issue price.

Methodhub Software IPO is a book build issue of ₹103.02 crore. The issue is a combination of fresh issue of 0.45 crore shares, aggregate value of ₹87.50 crore and offer for sale of 0.08 crore shares, aggregate value of ₹15.52 crore. Bidding for Methodhub Software IPO will open for subscription on December 5, 2025 and close on December 9, 2025. The allotment of Methodhub Software IPO is expected to be finalized on December 10, 2025. Methodhub Software IPO will be listed on BSE SME, with a tentative listing date of December 12, 2025. The price band of Methodhub Software IPO has been fixed at ₹190.00 to ₹194.00 per share. The lot size for one application is 600.

Wakefit Innovations IPO is a book build issue worth ₹1,288.89 crore. The issue is a combination of fresh issue of 1.93 crore shares, aggregating to ₹377.18 crore and offer for sale of 4.68 crore shares, aggregating to ₹911.71 crore. Wakefit Innovations IPO will open for subscription on December 8, 2025 and close on December 10, 2025. The allotment of Wakefit Innovations IPO is expected to be finalized on December 11, 2025. Wakefit Innovations IPO will be listed on BSE and NSE, the probable listing date of which has been fixed as December 15, 2025. The price band of Wakefit Innovations IPO has been fixed at ₹185.00 to ₹195.00 per share. The lot size for an application is 76.

Flywings Simulator Training IPO is a book build issue worth ₹57.05 crore. The issue is a fresh issue of 0.25 crore new shares, having an aggregate value of ₹47.99 crore, and an offer for sale of 0.05 crore shares, having an aggregate value of ₹9.05 crore. Bidding for Flywings Simulator Training IPO will open for subscription on December 5, 2025 and will close on December 9, 2025. The allotment of Flywings Simulator Training IPO is expected to be finalized on December 10, 2025. Flywings Simulator Training IPO will be listed on NSE SME, with a tentative listing date of December 12, 2025. The price band of Flywings Simulator Training IPO has been fixed at ₹181.00 to ₹191.00 per share.

Luxury Time IPO is a book build issue of ₹18.74 crore. The issue is a combination of fresh issue of 0.18 crore shares, aggregating to ₹15.00 crore and offer for sale of 0.05 crore shares, aggregating to ₹3.74 crore. Luxury Time IPO will open for subscription on December 4, 2025 and close on December 8, 2025. The allotment for the Luxury Time IPO is expected to be final on December 9, 2025. Luxury Time IPO will be listed on BSE SME and the tentative date of listing has been fixed as December 11, 2025. The price band of Luxury Time IPO has been fixed at ₹78.00 to ₹82.00 per share.

Western Overseas Study Abroad Ltd. The IPO is a fixed price issue of ₹10.07 crore. The issue is entirely a fresh issue of 0.18 crore shares worth ₹10.07 crore. Western Overseas Study Abroad Ltd. The IPO will open for subscription on 4 December 2025 and close on 8 December 2025. Western Overseas Study Abroad Ltd. The allotment of the IPO is expected to be finalized on December 9, 2025. Western Overseas Study Abroad IPO will be listed on BSE SME, the probable listing date of which has been fixed as 11 December 2025. Western Overseas Study Abroad Ltd. The price band of the IPO is ₹56.00 per share.